Aspire Biopharma files 1-for-30 reverse stock split

Aspire Biopharma Holdings, Inc.

Filed 1-for-30 reverse stock split of common stock on May 11, 2026.
Fractional shares rounded up; no fractional shares will be issued in the split.
Ticker symbol remains ASBP; new CUSIP number is 738920305.
Effective date set in the Certificate of Amendment filed with Delaware Secretary of State.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aspire Biopharma Holdings, Inc.: Amended Article Fourth of Certificate of Incorporation to effect a 1-for-30 reverse stock split (effective 2026-05-11).

Change: charter amendment
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, Aspire Biopharma Holdings, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”). Pursuant to the Certificate of Amendment, the Company amended Article Fourth of its Certificate of Incorporation to effect a 1-for-30 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Split”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-023069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.